Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
7.92
-0.42 (-5.04%)
At close: Dec 5, 2025, 4:00 PM EST
8.25
+0.33 (4.17%)
After-hours: Dec 5, 2025, 7:35 PM EST
DAWN Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -151.76 | -95.5 | -188.92 | -142.18 | -70.65 | -40.51 | |
| Depreciation & Amortization | 3.55 | 2.03 | 0.38 | 0.53 | 0.2 | 0.16 | |
| Asset Writedown & Restructuring Costs | - | 55 | 3 | - | 8 | - | |
| Loss (Gain) From Sale of Investments | -15.35 | -6.39 | -10.08 | -2.03 | - | - | |
| Stock-Based Compensation | 44.36 | 48.26 | 39.34 | 27.24 | 13.32 | 0.53 | |
| Other Operating Activities | - | -108 | - | - | -2.11 | 26.69 | |
| Change in Accounts Receivable | -8 | -13.88 | - | - | - | - | |
| Change in Inventory | -4.19 | -3.24 | - | - | - | - | |
| Change in Accounts Payable | 2.76 | 0.69 | 2.32 | -1.48 | 1.54 | 0.13 | |
| Change in Unearned Revenue | 0.75 | 4.79 | - | - | - | - | |
| Change in Other Net Operating Assets | 8.2 | 38.13 | 7.1 | 8.05 | 1.15 | -0.49 | |
| Operating Cash Flow | -119.62 | -78.11 | -146.85 | -109.87 | -48.54 | -13.49 | |
| Capital Expenditures | -1.74 | -2.17 | -0.22 | -0.03 | - | -0.09 | |
| Sale (Purchase) of Intangibles | -3.5 | -72.1 | -3 | - | -8 | - | |
| Investment in Securities | -257.26 | -264.73 | 131.6 | -255.05 | - | - | |
| Other Investing Activities | - | 108 | - | - | - | - | |
| Investing Cash Flow | -262.47 | -230.99 | 128.38 | -255.07 | -8 | -0.09 | |
| Issuance of Common Stock | 2.6 | 182.35 | 164 | 165.9 | 167.36 | - | |
| Other Financing Activities | - | 20.94 | - | - | - | - | |
| Financing Cash Flow | 2.6 | 203.29 | 164 | 165.9 | 297.12 | 29.98 | |
| Net Cash Flow | -379.49 | -105.82 | 145.52 | -199.05 | 240.58 | 16.4 | |
| Free Cash Flow | -121.36 | -80.28 | -147.08 | -109.9 | -48.54 | -13.58 | |
| Free Cash Flow Margin | -90.79% | -61.21% | - | - | - | - | |
| Free Cash Flow Per Share | -1.18 | -0.86 | -1.84 | -1.68 | -1.31 | -2.46 | |
| Cash Income Tax Paid | 6.33 | 1.9 | - | - | - | - | |
| Levered Free Cash Flow | -59.99 | -133.99 | -82.72 | -56.86 | -37.01 | -9.6 | |
| Unlevered Free Cash Flow | -59.99 | -133.99 | -82.72 | -56.86 | -37.01 | -9.58 | |
| Change in Working Capital | -0.49 | 26.48 | 9.42 | 6.56 | 2.7 | -0.36 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.